or Try an Advanced Search...

    Technical Analysis for DSGN - Design Therapeutics, Inc.

    Grade Last Price % Change Price Change
    B 3.65 -0.27% -0.01
    DSGN closed down 0.27 percent on Wednesday, April 24, 2024, on 67 percent of normal volume.
    Earnings due: May 7
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Down
    Historical DSGN trend table...
    Date Alert Name Type % Chg
    Golden Cross Bullish 0.00%
    Gapped Down Weakness 0.00%
    Fell Below 20 DMA Bearish -0.27%
    Crossed Above 20 DMA Bullish -6.17%
    180 Bullish Setup Bullish Swing Setup -6.17%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -6.17%
    Outside Day Range Expansion -6.17%
    20 DMA Resistance Bearish -1.35%
    Fell Below 20 DMA Bearish -2.41%
    Inside Day Range Contraction -2.41%
    Older End-of-Day Signals for DSGN ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 20 hours ago
    Up 1% about 23 hours ago
    Fell Below Previous Day's Low about 24 hours ago
    Down 2 % about 24 hours ago
    Down 1% about 24 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    DSGN Chart by TradingView
    Basic chart:

    Profile

    Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Rare Diseases Medical Genetics Neurological Disorders Stroke Degenerative Disease Myotonic Dystrophy Ataxia Fragile X Syndrome Friedreich's Ataxia Trinucleotide Repeat Disorders

    Is DSGN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 27 Independent Director of Design Therapeutics Picks Up 88% More Stock
    Mar 26 Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
    Mar 20 Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript
    Mar 20 Q4 2023 Design Therapeutics Inc Earnings Call
    Mar 20 Design Therapeutics, Inc. (DSGN) Q4 2023 Earnings Call Transcript
    Mar 19 Design Therapeutics GAAP EPS of -$0.21 beats by $0.11
    Mar 19 Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
    Mar 12 Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
    Dec 18 Design Therapeutics, Inc. (DSGN) Upgraded to Buy: Here's What You Should Know
    Nov 25 Positive Signs As Multiple Insiders Buy Design Therapeutics Stock
    See more DSGN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.47
    52 Week Low 1.94
    Average Volume 288,597
    200-Day Moving Average 3.18
    50-Day Moving Average 3.21
    20-Day Moving Average 3.78
    10-Day Moving Average 3.75
    Average True Range 0.27
    RSI (14) 52.38
    ADX 19.03
    +DI 17.03
    -DI 16.12
    Chandelier Exit (Long, 3 ATRs) 3.33
    Chandelier Exit (Short, 3 ATRs) 4.23
    Upper Bollinger Bands 4.03
    Lower Bollinger Band 3.54
    Percent B (%b) 0.23
    BandWidth 12.88
    MACD Line 0.14
    MACD Signal Line 0.19
    MACD Histogram -0.05
    Fundamentals Value
    Market Cap 204.41 Million
    Num Shares 56 Million
    EPS -1.29
    Price-to-Earnings (P/E) Ratio -2.83
    Price-to-Sales 22642.01
    Price-to-Book 0.45
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.91
    Resistance 3 (R3) 3.91 3.82 3.87
    Resistance 2 (R2) 3.82 3.75 3.82 3.85
    Resistance 1 (R1) 3.74 3.71 3.78 3.74 3.84
    Pivot Point 3.64 3.64 3.67 3.65 3.64
    Support 1 (S1) 3.56 3.58 3.60 3.56 3.46
    Support 2 (S2) 3.47 3.54 3.47 3.45
    Support 3 (S3) 3.38 3.47 3.43
    Support 4 (S4) 3.39